Morphological and functional evaluation of oral nutritional supplements in primary open-angle glaucoma treatment—first results
Bulgarian Review of Ophthalmology · 2023
DOI: 10.14748/bro.v67i1.8592 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bulgarian Review of Ophthalmology, 2023. Verfasst von Konstantina Kancheva und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Introduction
Glaucoma is a chronic progressive optic neuropathy characterized by pathological degeneration of retinal ganglion cells (RGCs), with structural damage to the optic nerve and visual field loss.
Aim
To study the effect of the oral dietary supplement MieloOptik as an adjuvant therapy in patients with primary open-angle glaucoma (POAG). Materials and Methods: This study included examination results of both eyes of 60 patients with POAG. The patients were randomly divided into 2 groups of 30 participants, aged 50–75 years, who were receiving topical anti-glaucoma therapy, with intraocular pressure (IOP) values between 14 and 21 mmHg. The patients from group A took the dietary supplement MieloOptik for a period of 6 months. Those in group B did not take any nutritional supplements that could positively or negatively affect the results of the study. All patients underwent a complete ophthalmological examination, including best-corrected visual acuity examination for each eye, Goldmann tonometry, ophthalmoscopy, gonioscopy, pachymetry, standard automated perimetry (SAP), and optical coherence tomography (OCT) at the start of the study and after 6 months.
Results
After 6 months, the mean deviation (MD) values from SAP in group A was statistically significantly lower (p < 0.05), by 0.59, than those at baseline. The pattern standard deviation (PSD) values of group A were statistically significantly lower (p < 0.05), by 0.69, than those at baseline. Both MD and PSD significantly (p < 0.05) decreased over time. The corresponding parameters in group B patients showed a statistically significant deterioration (p < 0.05) during the 6-month observation period.
Conclusion
These findings suggest that taking the nutritional supplement MieloOptik as adjuvant therapy for patients with POAG appears to be effective in slowing the progression of the disease. Further studies on a larger population and with longer follow-up are needed to confirm this pilot investigation.
Zitieren
APA
Kancheva, K., & Zlatarova, Z. (2023). Morphological and functional evaluation of oral nutritional supplements in primary open-angle glaucoma treatment—first results. Bulgarian Review of Ophthalmology. https://doi.org/10.14748/bro.v67i1.8592
Vancouver
Kancheva K, Zlatarova Z. Morphological and functional evaluation of oral nutritional supplements in primary open-angle glaucoma treatment—first results. Bulgarian Review of Ophthalmology. 2023. doi:10.14748/bro.v67i1.8592
BibTeX
@article{Kancheva2023,
author = {Kancheva, Konstantina and Zlatarova, Zornitsa},
title = {Morphological and functional evaluation of oral nutritional supplements in primary open-angle glaucoma treatment—first results},
journal = {Bulgarian Review of Ophthalmology},
year = {2023},
doi = {10.14748/bro.v67i1.8592}
}
EUVIMED